Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

32
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
32
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

2.2K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.2K
Stress Prevention and Stress Management Techniques IV01:26

Stress Prevention and Stress Management Techniques IV

366
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
366
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

5.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

73
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
73
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

205
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
205

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiple sclerosis and the limits of classical autoimmune theory.

Frontiers in immunology·2026
Same author

Trajectories of processing speed in multiple sclerosis across disease-modifying therapies.

Journal of neurology·2026
Same author

Non-MRI biomarkers should be accepted to guide treatment escalation in MS: Commentary.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Should autologous HSCT be a first-line option in highly active MS? Commentary.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Dental-amalgam exposure and the risk and progression of multiple sclerosis.

International journal of epidemiology·2026
Same author

Long-term disability after initiation of platform versus high-efficacy disease-modifying therapy in relapsing-onset multiple sclerosis.

Journal of neurology·2026
Same journal

Different risks, same causes: educational attainment influences when, not from what, we die.

European journal of epidemiology·2026
Same journal

Loneliness around the world: patterns, predictors, and well-being implications.

European journal of epidemiology·2026
Same journal

Cohort profile: Swiss personalized health network cohort consortium.

European journal of epidemiology·2026
Same journal

The SINTER study: a recall-by-genotype design with multidimensional musculoskeletal phenotyping across internal-medicine outpatient clinics.

European journal of epidemiology·2026
Same journal

SARS-CoV-2 infection as a trigger of type 2 diabetes in adults: a population-based cohort study in Sweden using a double negative control design.

European journal of epidemiology·2026
Same journal

Cohort profile: transformative research on equity and social determinants to uplift resilience and empower LGBTQ+ health in China (TREASURE).

European journal of epidemiology·2026
See all related articles

Related Experiment Video

Updated: May 6, 2026

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
06:07

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Published on: October 22, 2020

6.7K

Smoking and multiple sclerosis susceptibility.

Anna Karin Hedström1, Jan Hillert, Tomas Olsson

  • 1Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, anna.hedstrom@ki.se.

European Journal of Epidemiology
|October 23, 2013
PubMed
Summary
This summary is machine-generated.

Smoking significantly elevates multiple sclerosis (MS) risk, with effects diminishing a decade after cessation. This risk is dose-dependent and not influenced by age at smoking debut.

More Related Videos

Isolation of Mouse Respiratory Epithelial Cells and Exposure to Experimental Cigarette Smoke at Air Liquid Interface
10:47

Isolation of Mouse Respiratory Epithelial Cells and Exposure to Experimental Cigarette Smoke at Air Liquid Interface

Published on: February 21, 2011

33.9K
Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
10:37

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Published on: January 16, 2015

12.8K

Related Experiment Videos

Last Updated: May 6, 2026

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
06:07

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Published on: October 22, 2020

6.7K
Isolation of Mouse Respiratory Epithelial Cells and Exposure to Experimental Cigarette Smoke at Air Liquid Interface
10:47

Isolation of Mouse Respiratory Epithelial Cells and Exposure to Experimental Cigarette Smoke at Air Liquid Interface

Published on: February 21, 2011

33.9K
Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
10:37

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Published on: January 16, 2015

12.8K

Area of Science:

  • Neurology
  • Epidemiology
  • Public Health

Background:

  • Smoking is a well-established risk factor for multiple sclerosis (MS).
  • Understanding the nuances of smoking's impact on MS risk is crucial for prevention and management.

Purpose of the Study:

  • To investigate how smoking debut age, duration, intensity, cumulative dose, and cessation affect multiple sclerosis risk.
  • To quantify the dose-response relationship between smoking and MS.
  • To determine the long-term impact of smoking cessation on MS risk.

Main Methods:

  • Two Swedish population-based case-control studies.
  • Inclusion of 7,883 cases and 9,264 controls.
  • Calculation of odds ratios with 95% confidence intervals to assess MS risk associated with smoking habits.

Main Results:

  • A significant dose-response association was observed between cumulative smoking dose and MS risk (p <10(-35)).
  • Both smoking duration and intensity independently increased MS risk.
  • The adverse effects of smoking on MS risk abated approximately 10 years after smoking cessation, irrespective of cumulative dose.
  • Age at smoking debut did not influence the smoking-MS risk association.

Conclusions:

  • Smoking increases multiple sclerosis risk in a dose-dependent manner.
  • Unlike some other MS risk factors, smoking's impact is independent of exposure age.
  • Smoking cessation gradually reduces MS risk over time, with effects diminishing a decade post-cessation.